BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36906400)

  • 1. Improving sarcoma classification by using RNA hybridisation capture sequencing in sarcomas of uncertain histogenesis of young individuals.
    Vargas AC; Heyer EE; Cheah AL; Bonar F; Jones M; Maclean FM; Gill AJ; Blackburn J
    Pathology; 2023 Jun; 55(4):478-485. PubMed ID: 36906400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcomas with sclerotic epithelioid phenotype harboring novel EWSR1-SSX1 fusions.
    Antonescu CR; Rosenberg AE; Xie Z; Zhang L; Perell KA; Loya AC
    Genes Chromosomes Cancer; 2021 Sep; 60(9):616-622. PubMed ID: 33987888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma Showcase.
    Decock A; Creytens D; Lefever S; Van der Meulen J; Anckaert J; De Ganck A; Deleu J; De Wilde B; Fierro C; Kuersten S; Luypaert M; Rottiers I; Schroth GP; Steyaert S; Vanderheyden K; Vanden Eynde E; Verniers K; Verreth J; Van Dorpe J; Vandesompele J
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New fusion sarcomas: histopathology and clinical significance of selected entities.
    Miettinen M; Felisiak-Golabek A; Luiña Contreras A; Glod J; Kaplan RN; Killian JK; Lasota J
    Hum Pathol; 2019 Apr; 86():57-65. PubMed ID: 30633925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KMT2A (MLL) fusions in aggressive sarcomas in young adults.
    Yoshida A; Arai Y; Tanzawa Y; Wakai S; Hama N; Kawai A; Shibata T
    Histopathology; 2019 Oct; 75(4):508-516. PubMed ID: 31136005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
    Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
    Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
    Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
    Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.
    Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR
    Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours.
    Zago Baltazar R; Claerhout S; Vander Borght S; Spans L; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Renard M; van den Hout MF; Vernemmen A; Libbrecht L; De Roo AK; Mazzeo F; van Marcke C; Deraedt K; Bourgain C; Vanden Bempt I
    J Pathol Clin Res; 2024 May; 10(3):e12376. PubMed ID: 38738521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
    Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
    Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
    Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
    J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts.
    Pižem J; Šekoranja D; Zupan A; Boštjančič E; Matjašič A; Mavčič B; Contreras JA; Gazič B; Martinčič D; Snoj Ž; Limpel Novak KA; Salapura V
    Am J Surg Pathol; 2020 Dec; 44(12):1623-1634. PubMed ID: 32991339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.
    Peters TL; Kumar V; Polikepahad S; Lin FY; Sarabia SF; Liang Y; Wang WL; Lazar AJ; Doddapaneni H; Chao H; Muzny DM; Wheeler DA; Okcu MF; Plon SE; Hicks MJ; López-Terrada D; Parsons DW; Roy A
    Mod Pathol; 2015 Apr; 28(4):575-86. PubMed ID: 25360585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.
    Lanic MD; Le Loarer F; Rainville V; Sater V; Viennot M; Beaussire L; Viailly PJ; Angot E; Hostein I; Jardin F; Ruminy P; Laé M
    Mod Pathol; 2022 May; 35(5):649-663. PubMed ID: 35075283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.
    Antonescu CR; Dickson BC; Zhang L; Sung YS; Fletcher CD
    Mod Pathol; 2021 Aug; 34(8):1541-1546. PubMed ID: 33859361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum.
    Brčić I; Brodowicz T; Cerroni L; Kashofer K; Serbanescu GL; Kasseroler MT; Amann G; Scheipl S; Szkandera J; Leithner A; Liegl-Atzwanger B
    Pathology; 2020 Feb; 52(2):236-242. PubMed ID: 31870501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing an RNA fusions panel in soft tissue sarcoma with clinical validation.
    Huang X; Li G; Li L; Wang J; Shen J; Chen Y; Yu W; Chen A; Wu T; Ma J; Ling B; He L; Chen X
    Sci Rep; 2023 Mar; 13(1):4403. PubMed ID: 36928336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.
    Hu W; Yuan L; Zhang X; Ni Y; Hong D; Wang Z; Li X; Ling Y; Zhang C; Deng W; Tian M; Ding R; Song C; Li J; Zhang X
    Cancer Sci; 2022 May; 113(5):1843-1854. PubMed ID: 35238118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging
    Brcic I; Scheipl S; Bergovec M; Leithner A; Szkandera J; Sotlar K; Suda AJ; Smolle MA; Kraus T; Rosenberg AE; Liegl-Atzwanger B; Igrec J
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.